The Federal Food and Drug Administration (FDA) has recently approved Eli Lilly’s EBGLYSS as a treatment for moderate-to-severe atopic dermatitis (eczema). EBGLYSS is now approved for adults and ...
People with moderate to severe atopic dermatitis (a type of eczema) may not be able to control their symptoms with topical treatments that are applied to the skin. In these cases, oral or ...